These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26733206)

  • 1. VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model.
    Gallino L; Calo G; Hauk V; Fraccaroli L; Grasso E; Vermeulen M; Leirós CP; Ramhorst R
    Sci Rep; 2016 Jan; 6():18633. PubMed ID: 26733206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide induces an immunosuppressant microenvironment in the maternal-fetal interface of non-obese diabetic mice and improves early pregnancy outcome.
    Hauk V; Azzam S; Calo G; Gallino L; Paparini D; Franchi A; Ramhorst R; Pérez Leirós C
    Am J Reprod Immunol; 2014 Feb; 71(2):120-30. PubMed ID: 24405265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIP Promotes Recruitment of Tregs to the Uterine-Placental Interface During the Peri-Implantation Period to Sustain a Tolerogenic Microenvironment.
    Gallino L; Hauk V; Fernández L; Soczewski E; Gori S; Grasso E; Calo G; Saraco N; Berensztein E; Waschek JA; Pérez Leirós C; Ramhorst R
    Front Immunol; 2019; 10():2907. PubMed ID: 31969877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice.
    Roca V; Calafat M; Larocca L; Ramhorst R; Farina M; Franchi AM; Leirós CP
    Reproduction; 2009 Oct; 138(4):733-42. PubMed ID: 19633131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response.
    Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Calo G; Pérez Leirós C; Ramhorst R
    Clin Exp Immunol; 2012 Dec; 170(3):310-20. PubMed ID: 23121672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between decidual leukocyte infiltration and spontaneous abortion in a murine model of early fetal resorption.
    Duclos AJ; Pomerantz DK; Baines MG
    Cell Immunol; 1994 Dec; 159(2):184-93. PubMed ID: 7994753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone and VIP cross-talk enhances phagocytosis and anti-inflammatory profile in trophoblast-derived cells.
    Vota D; Aguero M; Grasso E; Hauk V; Gallino L; Soczewski E; Pérez Leirós C; Ramhorst R
    Mol Cell Endocrinol; 2017 Mar; 443():146-154. PubMed ID: 28104390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells.
    Fraccaroli L; Alfieri J; Larocca L; Calafat M; Roca V; Lombardi E; Ramhorst R; Leirós CP
    Br J Pharmacol; 2009 Jan; 156(1):116-26. PubMed ID: 19133995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells.
    Haddad EK; Duclos AJ; Baines MG
    J Exp Med; 1995 Oct; 182(4):1143-51. PubMed ID: 7561687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M; Pozo D; Martinez C; Leceta J; Calvo JR; Ganea D; Gomariz RP
    J Immunol; 1999 Feb; 162(4):2358-67. PubMed ID: 9973516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.
    Juarranz Y; Abad C; Martinez C; Arranz A; Gutierrez-Cañas I; Rosignoli F; Gomariz RP; Leceta J
    Arthritis Res Ther; 2005; 7(5):R1034-45. PubMed ID: 16207319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock.
    Delgado M; Gomariz RP; Martinez C; Abad C; Leceta J
    Eur J Immunol; 2000 Nov; 30(11):3236-46. PubMed ID: 11093139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vasoactive intestinal peptide to immune homeostasis in trophoblast-maternal leukocyte interaction under LPS stimulation.
    Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Pérez Leirós C; Ramhorst R
    Neuroimmunomodulation; 2014; 21(1):21-30. PubMed ID: 24135863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage depletion and TNF-α inhibition prevent resorption in CBA/J × DBA/2 model of CpG-induced abortion.
    Kang X; Zhang X; Zhao A
    Biochem Biophys Res Commun; 2016 Jan; 469(3):704-10. PubMed ID: 26686416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK.
    Mas AE; Petitbarat M; Dubanchet S; Fay S; Ledée N; Chaouat G
    Am J Reprod Immunol; 2008 Apr; 59(4):323-38. PubMed ID: 18336386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M; Leceta J; Gomariz RP; Ganea D
    J Immunol; 1999 Oct; 163(7):3629-35. PubMed ID: 10490956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.